For: |
Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i3/794.htm |
Number | Citing Articles |
1 |
Marc Thiriet. Vasculopathies. Biomathematical and Biomechanical Modeling of the Circulatory and Ventilatory Systems 2018; 8: 331 doi: 10.1007/978-3-319-89315-0_5
|
2 |
Gemma Aragonès, Teresa Auguet, Sandra Armengol, Alba Berlanga, Esther Guiu-Jurado, Carmen Aguilar, Salomé Martínez, Fátima Sabench, José Porras, Maikel Ruiz, Mercé Hernández, Joan Sirvent, Daniel Del Castillo, Cristóbal Richart. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(5): 630 doi: 10.3390/ijms17050630
|
3 |
Rocío Aller, Cristina Laserna, Miguel Ángel Rojo, Natalia Mora, Concepción García Sánchez, María Pina, Rebeca Sigüenza, Miguel Dur�, David Primo, Olatz Izaola, Daniel de Luis. Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease. Revista Española de Enfermedades Digestivas 2018; 110 doi: 10.17235/reed.2018.5602/2018
|
4 |
Cosimo Colletta, Alessandro Colletta, Giuseppe Placentino. Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. Journal of Diabetes & Metabolic Disorders 2020; 19(2): 883 doi: 10.1007/s40200-020-00576-3
|
5 |
Mojtaba Najafi, Alireza Rafiei, Alireza Ghaemi, Vahid Hosseini. Association between rs738408, rs738409 and rs139051polymorphisms in PNPLA3 gene and non-alcoholic fatty liver disease. Gene Reports 2022; 26: 101472 doi: 10.1016/j.genrep.2021.101472
|
6 |
Basel G. Aldroubi, John A. Najjar, Tya S. Youssef, Carl E. Rizk, Basil A.M. Abuamreh, Karl Aramouni, Hilda E. Ghadieh, Sonia M. Najjar. Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.48
|
7 |
Raffaella Tortora, Antonio Rispo, Anna Alisi, Nicola Imperatore, Annalisa Crudele, Francesca Ferretti, Valerio Nobili, Luca Miele, Nicolò Gerbino, Nicola Caporaso, Filomena Morisco. PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease. Nutrients 2018; 10(9): 1239 doi: 10.3390/nu10091239
|
8 |
Ina Bergheim, Detlef Schuppan. The Gut Microbiome in Health and Disease. 2018; : 279 doi: 10.1007/978-3-319-90545-7_17
|
9 |
Veronica A. Mullins, William Bresette, Laurel Johnstone, Brian Hallmark, Floyd H. Chilton. Genomics in Personalized Nutrition: Can You “Eat for Your Genes”?. Nutrients 2020; 12(10): 3118 doi: 10.3390/nu12103118
|
10 |
Iván López-Mendez, Juan Luis Romero-Flores, Graciela Castro-Narro, Misael Uribe, Eva Juárez-Hernández. Factors associated with obtaining lower IQR-CAP values in the detection of hepatic steatosis by transient elastography. Annals of Hepatology 2025; 30(1): 101762 doi: 10.1016/j.aohep.2024.101762
|
11 |
Zongsheng Huang, Xianwen Guo, Guo Zhang, Liexin Liang, Bing Nong. Correlation between PNPLA3 rs738409 polymorphism and hepatocellular carcinoma: a meta-analysis of 10,330 subjects. The International Journal of Biological Markers 2019; 34(2): 117 doi: 10.1177/1724600818812471
|
12 |
A. M. Gressner, O. A. Gressner. Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin 2019; : 857 doi: 10.1007/978-3-662-48986-4_3729
|
13 |
Jennifer L. Anderson, Teresa M. Kruisselbrink, Emily C. Lisi, Therese M. Hughes, Joan M. Steyermark, Erin M. Winkler, Corinne M. Berg, Robert A. Vierkant, Ruchi Gupta, Ahmad H. Ali, Stephanie S. Faubion, Stacy L. Aoudia, Tammy M. McAllister, Gianrico Farrugia, A. Keith Stewart, Konstantinos N. Lazaridis. Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice Setting. Mayo Clinic Proceedings 2021; 96(6): 1407 doi: 10.1016/j.mayocp.2020.08.051
|
14 |
Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Ou-Yang Huang, Rafael S. Rios, Kenneth I. Zheng, Sui-Dan Chen, Hong-Lei Ma, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2022; 10(3): 439 doi: 10.14218/JCTH.2021.00286
|
15 |
Rohan Mahabaleshwarkar, Tsai-Ling Liu, Iain H. McKillop, Melanie Spencer. The Association Between Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease Diagnosis Varies by Race. Metabolic Syndrome and Related Disorders 2022; doi: 10.1089/met.2021.0108
|
16 |
A. M. Gressner, O. A. Gressner. Lexikon der Medizinischen Laboratoriumsdiagnostik. 2018; : 1 doi: 10.1007/978-3-662-49054-9_3729-1
|
17 |
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
|
18 |
Fan Shi, Mei Zhao, Shudan Zheng, Lihong Zheng, Haiqiang Wang. Advances in genetic variation in metabolism-related fatty liver disease. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1213916
|
19 |
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
|
20 |
Youxia Wang, Xiaoling Chen, Zhiqing Huang, Daiwen Chen, Bing Yu, Jie Yu, Hong Chen, Jun He, Yuheng Luo, Ping Zheng. Dietary Ferulic Acid Supplementation Improves Antioxidant Capacity and Lipid Metabolism in Weaned Piglets. Nutrients 2020; 12(12): 3811 doi: 10.3390/nu12123811
|
21 |
Amal A. Mohamed, Rania Al Dweik, Reem A. Abdelghafour, Ahmed Ramadan, Abbas M. Abbas, Hussein H. Samir, Nashwa M. Muharram, Randa Ibrahim Ahmed Elshiha, Naglaa El-Salawy, Doaa Ghaith, Marwa K. Darwish, Soha M. Abd El Salam, Eman A. Sultan, Amina S. Soliman, Mohamed Ezz AL Arab, Ahmed Yosri Elamir, Ahmed Ali Mohamed, Al-Shaymaa A. Hassanin, Alaa Ali Mohamed Abouaggour, Wael Hafez, Mohamed M. Omran. Anthropometry, laboratory, and PNPLA3 polymorphisms in a novel model for early identification and evaluation of nonalcoholic fatty liver disease. Informatics in Medicine Unlocked 2024; 48: 101513 doi: 10.1016/j.imu.2024.101513
|
22 |
Angeliki Meritsi, Emanuel Manesis, Panagiotis Koussis, Stamatia Rapti, Dimitra Latsou, Eustathios Tsitsopoulos, Hariklia Moshoyianni, Spilios Manolakopoulos, Dimitrios Pektasides, Anastasia Thanopoulou. PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus. Metabolic Syndrome and Related Disorders 2022; 20(2): 124 doi: 10.1089/met.2021.0098
|
23 |
Awol Mekonnen Ali, Haileyesus Adam, Daniel Hailu, Rawleigh Howe, Teferra Abula, Marieke JH Coenen. Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia. The Application of Clinical Genetics 2023; : 131 doi: 10.2147/TACG.S404695
|
24 |
Flavio A. Cadegiani. Dietary Interventions in Liver Disease. 2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
|
25 |
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina. Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights. Clinical and Molecular Hepatology 2020; 26(4): 728 doi: 10.3350/cmh.2020.0202
|
26 |
Joseph L. Wilkerson, Sean M. Tatum, William L. Holland, Scott A. Summers. Ceramides are fuel gauges on the drive to cardiometabolic disease. Physiological Reviews 2024; 104(3): 1061 doi: 10.1152/physrev.00008.2023
|
27 |
Lizhen Chen, Zhonghua Lin, Man Jiang, Linlin Lu, Haiying Zhang, Yongning Xin, Xiangjun Jiang, Shiying Xuan. Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population. Hepatitis Monthly 2015; 15(10) doi: 10.5812/hepatmon.31076
|
28 |
Wei-Kei Wong, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics 2021; 43(3): 473 doi: 10.1016/j.clinthera.2021.01.007
|
29 |
Altayeb Ahmed, Madeleine Cule, Jimmy D. Bell, Naveed Sattar, Hanieh Yaghootkar. Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer. Journal of Hepatology 2024; 81(6): 921 doi: 10.1016/j.jhep.2024.06.030
|
30 |
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina 2023; 59(9): 1614 doi: 10.3390/medicina59091614
|
31 |
Georgios Sfikas, Michael Psallas, Charalambos Koumaras, Konstantinos Imprialos, Evangelos Perdikakis, Michael Doumas, Olga Giouleme, Asterios Karagiannis, Vasilios G. Athyros. Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?. Current Vascular Pharmacology 2021; 19(5): 572 doi: 10.2174/1570161118666201015152921
|
32 |
Giuseppina Umano, Mariangela Martino, Nicola Santoro. The Association between Pediatric NAFLD and Common Genetic Variants. Children 2017; 4(6): 49 doi: 10.3390/children4060049
|
33 |
Nader Salari, Niloufar Darvishi, Kamran Mansouri, Hooman Ghasemi, Melika Hosseinian-Far, Fateme Darvishi, Masoud Mohammadi. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00789-4
|
34 |
Annelise M. Poss, Scott A. Summers. Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00505
|
35 |
Le Zhang, Mortada El-Shabrawi, Louise A. Baur, Christopher D. Byrne, Giovanni Targher, Mohit Kehar, Gilda Porta, Way Seah Lee, Sander Lefere, Serap Turan, Anna Alisi, Ram Weiss, Maria Felicia Faienza, Ambika Ashraf, Shikha S. Sundaram, Anshu Srivastava, Ruth De Bruyne, Yunkoo Kang, Flora Bacopoulou, Yong-Hai Zhou, Andy Darma, Monica Lupsor-Platon, Masahide Hamaguchi, Anoop Misra, Nahum Méndez-Sánchez, Nicholas Beng Hui Ng, Claude Marcus, Amanda E. Staiano, Nadia Waheed, Saleh A. Alqahtani, Cosimo Giannini, Ponsiano Ocama, Mindie H. Nguyen, Maria Teresa Arias-Loste, Mohamed Rabea Ahmed, Giada Sebastiani, Yong Poovorawan, Mamun Al Mahtab, Juan M. Pericàs, Themis Reverbel da Silveira, Peter Hegyi, Amer Azaz, Hasan M. Isa, Chatmanee Lertudomphonwanit, Mona Issa Farrag, Ahmed Abd Alwahab Nugud, Hong-Wei Du, Ke-Min Qi, Nezha Mouane, Xin-Ran Cheng, Tawfiq Al Lawati, Eleonora D.T. Fagundes, Hasmik Ghazinyan, Adamos Hadjipanayis, Jian-Gao Fan, Nicoleta Gimiga, Naglaa M. Kamal, Gabriela Ștefănescu, Li Hong, Smaranda Diaconescu, Ming Li, Jacob George, Ming-Hua Zheng. An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease. Med 2024; 5(7): 797 doi: 10.1016/j.medj.2024.03.017
|
36 |
Xiaojiao Xu, Xiaoling Chen, Zhiqing Huang, Daiwen Chen, Jun He, Ping Zheng, Hong Chen, Junqiu Luo, Yuheng Luo, Bing Yu, Jie Yu. Effects of Dietary Apple Polyphenols Supplementation on Hepatic Fat Deposition and Antioxidant Capacity in Finishing Pigs. Animals 2019; 9(11): 937 doi: 10.3390/ani9110937
|